Daniel Veyel, PhD

Scientist
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

Disclosure information not submitted.

Presentation(s):

• Multi-Omics analysis mapping fibrotic changes in Bleomycin-induced pulmonary fibrosis in young and old mice

  Monday, February 7, 2022
  5:00 PM – 5:30 PM